Hibernia Wealth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Sell
1,126
-557
-33% -$130K 0.15% 60
2026
Q1
$411K Buy
1,683
+341
+25% +$79.4K 0.12% 70
2025
Q4
$277K Buy
+1,342
New +$265K 0.08% 85
2025
Q3
Sell
-2,057
Closed -$314K 73
2025
Q2
$314K Buy
+2,057
New +$316K 0.1% 76
2023
Q4
Sell
-174
Closed -$27.1K 206
2023
Q3
$27.1K Buy
+174
New +$28.7K 0.02% 113

Other funds holding JNJ

Hibernia Wealth Partners's JNJ Position: Q2 2026 in Review

Hibernia Wealth Partners reduced its Johnson & Johnson (JNJ) stake by 33% in Q2 2026, selling an estimated $130K and leaving 1,126 shares worth $286K. The position accounts for 0.15% of the portfolio, ranked #60.

Hibernia Wealth Partners first reported a position in JNJ in Q3 2023 and has held it in 5 quarters since. The position peaked at $411K in Q1 2026. 1,808 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Hibernia Wealth Partners held 1,126 shares of Johnson & Johnson worth $286K as of Q2 2026.
  • Hibernia Wealth Partners sold 557 Johnson & Johnson shares in Q2 2026, an estimated $130K.
  • Johnson & Johnson made up 0.15% of Hibernia Wealth Partners's portfolio in Q2 2026, its #60 holding.
  • Hibernia Wealth Partners first reported a position in Johnson & Johnson in Q3 2023 and has held it in 5 quarters since.
  • Hibernia Wealth Partners's Johnson & Johnson position peaked at $411K in Q1 2026.
  • 1,808 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Hibernia Wealth Partners's 13F filing for Q2 2026, filed 23 Jul 2026.